---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-070847"
form_type: "8-K"
ticker: "ASTH"
cik: "0001083446"
company_name: "Astrana Health, Inc."
filed_at: "2024-06-12T23:59:59+00:00"
generated_at: "2026-06-01T04:46:39.396579+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Shareholders approve 2024 Equity Incentive Plan adding 2.1M shares; all director nominees elected

## Summary
- All nine director nominees elected at June 12 annual meeting; quorum of 75.6%.
- 2024 Equity Incentive Plan approved (37.1M for); authorizes 2.1M new shares, replacing 2015 Plan.
- Advisory 'say-on-pay' passed (37.3M for); Ernst & Young ratified as auditor for FY 2024.
- Charter amendment adding officer exculpation provisions approved.
- Plan effective Feb 28, 2024; no changes to executive compensation or board composition.

## SEC filing metadata
- accession: 0001104659-24-070847
- form_type: 8-K
- ticker: ASTH
- cik: 0001083446
- company_name: Astrana Health, Inc.
- filed_at: 2024-06-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1083446/000110465924070847/0001104659-24-070847-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1083446/000110465924070847/tm2416687d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-070847
- JSON: https://secwatch.observer/filing/0001104659-24-070847.json
- Plain text: https://secwatch.observer/filing/0001104659-24-070847.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.